July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations about the promise of stem cells. The company will be accepting video entries for its “Resolution Revolution” ...
July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
For an expectant mother, there are a million details to worry about and a lot of important decisions to be made.
One of those decisions to be made is whether to bank your baby's umbilical cord blood. Cord blood is valuable because it's full of stem cells scientists and doctors can use ...
July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Dr. Joshua Hare believes medicine is close to a goal long thought to be impossible: healing the human heart.
The way to get there? Stem cells.
"These could be as big as antibiotics were in the last century," said Hare, who leads the University of Miami 's new Stem Cell Institute. "Stem ...
July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Researchers from Italy have reported that the injection of umbilical cord blood directly into the pelvic bones of patients with leukemia appears promising. These results were recently published in an early online publication of the Lancet Oncology on August 9, 2008.
Transplantation of bone marrow, peripheral blood stem cells, and umbilical cord blood is ...
July 10th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Women in the city will soon have the option of banking their menstrual blood so that menstrual blood stem cells can be used for treatment of serious disorders through stem cell therapy.
In six months, Life Cell International, in technology partnership with Cryo-Cell International, will set up the facility, which will be ...
On August 23-25, 2010, industry scientists, CEOs, and academics will convene at Philadelphia’s Four Seasons Hotel for the “Ubiquitin Drug Discovery and Diagnostics Conference” to discuss the Next Big Thing in drug discovery research—the ubiquitin pathway. Advances in oncology, infectious diseases, neurodegeneration, inflammation, diabetes, and muscle wasting will be covered.
A ...
A new website by The United Soybean Board (USB) highlights the important role biotechnology plays in allowing U.S. farmers to continue to meet the world’s food demand as well as ensuring our environment and food supply remains as safe as ever. Whether you know it as biotech, genetically modified or ...
May 13th 2010
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Healthcare,
Medicine,
Pharmaceuticals,
Science
No Comments
Cryo-Cell International, Inc. today announced results of a study published [this month] in the cover article of Stem Cells and Developmentshowing that stem cells found in menstrual blood may one day be a potential source for stem cell therapies in stroke and other central nervous system disorders. Menstrual stem cells, known as ...
October 27th 2008
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotechnology,
Gene,
Genetics,
Microarrays,
Pharmaceuticals,
Science
No Comments
Taking advantage of its flexible µParaflo™ Chip Technology, Houston based LC Sciences today announced immediate availability of probe content miRBase 10.0 for their microRNA (miRNA) microarray customers. This announcement comes less than a week after Sanger Institute’s update of their sequence database for known miRNAs (miRBase) 1 to version 10.0 (http://microrna.sanger.ac.uk/sequences). As the jump in
version numbers from ...
August 29th 2008
Categories:
Biochemicals,
Biological Remediation,
Biomedical Engineering,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Consulting,
DNA,
FDA,
Gene,
Gene Therapy,
Genetics,
Genome,
Healthcare,
Law,
Licenses,
Medical Technologies,
Medicine,
Microarrays,
Online,
Pharmaceuticals,
Policy,
Proteomics,
Regulations,
Science,
Tissue Engineering,
Vaccines
One Comment
EPR Biotech News is a new blog, part of EPR Network, that is going to be focused on and will be covering the biotech news and stories from press releases published on EPR Network.
EPR Network (EPR stands for express press release) is one of the nation’s largest press release distribution networks on Web. The EPR’s nationwide network includes 12 State based ...